Title : Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21
Title : Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21